FHI vs GBDC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 04, 2026

FHI

39.5
AI Score
VS
FHI Wins

GBDC

38.7
AI Score

Investment Advisor Scores

FHI

40score
Recommendation
EXTENDED

GBDC

39score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric FHI GBDC Winner
Forward P/E 9.7466 9.98 FHI
PEG Ratio 1.3728 1.395 FHI
Revenue Growth 8.1% -14.0% FHI
Earnings Growth 11.9% -35.1% FHI
Tradestie Score 39.5/100 38.7/100 FHI
Profit Margin 21.3% 21.4% GBDC
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED AVOID NEW MONEY FHI

Relative Price Performance (Last 90 Days)

FHI 1M: +14.4% · 3M: +1.3% GBDC 1M: +4.3% · 3M: -3.0%

Current Technical Phase

FHI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 68

RSI (14): 68.2 · Price: $63.99

GBDC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 56

RSI (14): 56.0 · Price: $12.74

Fundamentals Snapshot

Metric FHI GBDC
Market Cap — —
Forward P/E 10.7 10.0
Trailing P/E 11.9 19.6
Revenue (TTM) — —
Revenue Growth 0.1% -0.1%
Gross Margin 0.7% 1.0%
Operating Margin 0.3% 0.8%
EPS 5.39 0.66
Dividend Yield 0.02% 0.11%

Frequently Asked Questions

Based on our detailed analysis, FHI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.